September 19, 2011
Novartis Pharma announced on August 30 that it has filed an NDA for the aminoglycoside antibiotic tobramycin for the treatment of pulmonary infection by P. aeruginosa in patients with cystic fibrosis of the pancreas. Korosho had asked the company to...read more